ITGR Stock Analysis: Buy, Sell, or Hold?
ITGR - Integer Holdings Corporation
$86.58
0.14 (0.16%)
▲
5d:
-0.29%
30d:
+0.64%
90d:
+10.39%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 23, 2026
20d
Smart Money Distribution
ITGR is up 4.8% this week, but smart money is buying puts. Top strike: $65 2026-05-15 with 110 OI. Put ratio: 100% View Scanner →
Strength: 7.4/10
Get Alerted When ITGR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ITGR shows positive signals but monitor for confirmation. Market pricing in 1.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ITGR shows positive signals but monitor for confirmation. Market pricing in 1.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$131.42
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$81.60
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ITGR is currently trading at $86.58, which is considered slightly high relative to its 30-day fair value range of $84.32 to $86.90. The stock's valuation (Forward PE: 12.0) is in line with its historical norms (12.6). Remarkably, the market is currently pricing in an annual earnings decline of 1.7% over the next few years. This pessimistic expectation contrasts with the company's recent 52.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ITGR is in a strong uptrend. The price is approaching resistance at $89.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ITGR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ITGR is in a strong uptrend. The price is approaching resistance at $89.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ITGR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$84.32 -
$86.90
Company Quality Score
64/100
(BUY)
Options IV Signal
43th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
71.2%
All Signals
- NEUTRAL: Options fairly priced (IV 43th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($93.25)
Fair Price Analysis
30-Day Fair Range
$84.32 -
$86.90
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$7.23
(8.4%)
Support & Resistance Levels
Support Level
$83.44
Resistance Level
$89.07
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.96
Wall Street Target
$93.25
(+7.9%)
Revenue Growth (YoY)
5.0%
Earnings Growth (YoY)
52.9%
Profit Margin
5.5%
Valuation Discount vs History
-1.7% cheaper
PE vs Historical
12.0 vs 12.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.7%
(market-implied from PE analysis)
1-Year Target
$84.97
(-2%)
2-Year Target
$83.53
(-3%)
3-Year Target
$82.11
(-5%)
3-Yr Target (if PE normalizes)
(PE: 12→13)
$86.47
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 11.3%)
$222.72
(+158%)
Base:
(SPY PE: 12.0, Growth: 11.3%)
$119.22
(+38%)
Bear:
(PE: 10.2, Growth: 11.3%)
$101.34
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 29.10 | Current EPS (TTM): $2.89
Bull Case
$185.02
(+117%)
Analyst growth 100.0%, PE expands to 32.0
Base Case
$168.20
(+97%)
Market implied 100.0%, PE stable at 29.1
Bear Case
$57.19
(-33%)
Severe decline -20.0%, PE contracts to 24.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.0 to 12.6
Stabilization Target:
$91.04
(+5.3%)
PE Expansion Potential:
+5.3%
Share & Embed Analysis
Last updated: April 02, 2026 2:30 PM ET
Data refreshes hourly during market hours. Next update: 3:30 PM
Data refreshes hourly during market hours. Next update: 3:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ITGR showing a specific setup today?
Insider Activity (6 Months)
3
Buys
2
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Tommy P Thomas
SELL
825 shares
2026-03-13
Tommy P Thomas
SELL
884 shares
2025-11-11
Diron Smith
BUY
1116 shares
2025-11-07
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
Advanced ITGR Option Strategies
Professional options setups generated by AI based on today's ITGR price and gamma walls.
